SENIOR CARE PHARMACIST : Impact Factor & More
eISSN: 2639-9644pISSN: 2639-9636
Share this on:
Key Metrics
H-Index 
4
SJR
Q4Medicine (miscellaneous)
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
SENIOR CARE PHARMACIST Journal Specifications
Indexed in the following public directories
Web of Science
| Overview | |
| Publisher | AMER SOC CONSULTANT PHARMACISTS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2019 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in SENIOR CARE PHARMACIST ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in SENIOR CARE PHARMACIST
Comment on "Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer's Disease: Progress and Challenges".
- 1 Aug 2026
- The Senior care pharmacist
Fall Risk Factors in Older Patients with Sickle Cell Disease (SCD): A Narrative Review.
- 1 Aug 2026
- The Senior care pharmacist
Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.
- 1 Aug 2026
- The Senior care pharmacist
ASCP Members Help Explain Patient Disparities in California's End-of-Life Option Act Data.
- 1 Aug 2026
- The Senior care pharmacist
Home Sweet Home: From Nursing Homes to Aging in Place.
- 1 Aug 2026
- The Senior care pharmacist
Response to Comment on "Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer's Disease: Progress and Challenges".
- 1 Aug 2026
- The Senior care pharmacist
Comment on "Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer's Disease: Progress and Challenges".
- 1 Aug 2026
- The Senior care pharmacist
Fall Risk Factors in Older Patients with Sickle Cell Disease (SCD): A Narrative Review.
- 1 Aug 2026
- The Senior care pharmacist
Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.
- 1 Aug 2026
- The Senior care pharmacist
ASCP Members Help Explain Patient Disparities in California's End-of-Life Option Act Data.
- 1 Aug 2026
- The Senior care pharmacist
Home Sweet Home: From Nursing Homes to Aging in Place.
- 1 Aug 2026
- The Senior care pharmacist
Response to Comment on "Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer's Disease: Progress and Challenges".
- 1 Aug 2026
- The Senior care pharmacist
FAQs on SENIOR CARE PHARMACIST
How long has SENIOR CARE PHARMACIST been actively publishing? 
What is the publishing frequency of SENIOR CARE PHARMACIST?
How many articles did SENIOR CARE PHARMACIST publish last year?
What is the eISSN & pISSN for SENIOR CARE PHARMACIST?
What is the H Index for SENIOR CARE PHARMACIST ?
What is the SJR for SENIOR CARE PHARMACIST?
Who is the publisher of SENIOR CARE PHARMACIST?
